NPM1 and acute myeloid leukemia: In murine models of NPM1 mutant AML, transgenic expression of HOXBLINC enhanced symmetric self‐renewal of stem cells and reduced the proportion of cells undergoing symmetric differentiation (Zhu et al., 2021).